Autonomic Recalibration
CompletedNot applicableNCT06603168
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to learn if Autonomic Recalibration works to reduce sympathetic dominance to alleviate dysfunctional myofascial pain. The main questions it aims to answer are: How is the Autonomic Nervous System (ANS) affected during Autonomic Recalibration Treatment (ART)? How are myofascial tissue properties impacted from ART? Participants will: Have 2 treatments of ART on consecutive days. Wear sensors to track HRV (heart rate variability) and GSR to verify autonomic recalibration. Measure changes in range of motion by wearing a Rokoko motion capture suit. Measure changes in muscle stiffness through shear wave elastography.
Study details
- Official title
- Autonomic Recalibration Approach to Myofascial Pain Elimination
- Conditions
- Chronic Pain (Back / Neck)
- Autonomic Dysregulation
- Interventions
- Other: Autonomic Recalibration Treatment
- Sponsor
- Edward Via Virginia College of Osteopathic Medicine
- Start date
- 2023-04-27
- Primary completion
- 2023-08-24
- Sex
- All
- Age range
- from 21 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * dysfunctional myofascial pain, i.e., ongoing pain not relevant to an acute perturbation (e.g., recent injury) or known underlying condition (e.g., cancer). Exclusion Criteria: * known skin allergies to gel as found in common cosmetic or household products * can't make treatment appointments on two consecutive days * myofascial pain is deemed functional (normal response to acute injury or ongoing pathology) * lacking a COVID-19 vaccination and a booster shot.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06603168